A multi-institutional Clinical Core Unit (CCU) was established during the first five years of the Massachusetts ADRC and will continue during years 06 to 10. The three Units are at BAH, MGH, and UMMC. The overall goals of the CCU are to examine, diagnose, and enroll into the ADRC Patient Registry men and women with AD and related dementias , and health control subjects. An associated goal is to characterize the neurological, psychiatric, and neuropsychological features of AD across all stages of illness. The clinical experience at each Unit stimulates and supports new research initiatives, and enhances research productivity. In order to accomplish these goals, subjects are examined at one of the three clinical units; demographic and diagnostic information on all subjects are entered into the joint ADRC central Patient Registry. Standardized data are collected in each Unit on aspects of the clinical history of dementia, features of the neurological examination, results of cognitive tests, and laboratory diagnostic tests. These data are collected in a uniform manner at each of the three Units and maintained in separate but compatible databases. In order to track the course of illness, neurological and psychiatric examinations are repeated every six months; cognitive tests are performed every twelve months. Patients with AD are referred to specific research projects depending upon informed consent and the inclusion and exclusion criteria of each project. Patients with AD and control subjects are encouraged to sign a brain donation form indicating intent for postmortem examination.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
5P50AG005134-13
Application #
5204457
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
13
Fiscal Year
1996
Total Cost
Indirect Cost
Gallagher, Damien; Kiss, Alex; Lanctot, Krista et al. (2018) Depression and Risk of Alzheimer Dementia: A Longitudinal Analysis to Determine Predictors of Increased Risk among Older Adults with Depression. Am J Geriatr Psychiatry 26:819-827
Makaretz, Sara J; Quimby, Megan; Collins, Jessica et al. (2018) Flortaucipir tau PET imaging in semantic variant primary progressive aphasia. J Neurol Neurosurg Psychiatry 89:1024-1031
Haaksma, Miriam L; Calderón-Larrañaga, Amaia; Olde Rikkert, Marcel G M et al. (2018) Cognitive and functional progression in Alzheimer disease: A prediction model of latent classes. Int J Geriatr Psychiatry 33:1057-1064
Davis, Jeremy J (2018) Performance validity in older adults: Observed versus predicted false positive rates in relation to number of tests administered. J Clin Exp Neuropsychol 40:1013-1021
Wimalaratne, Sarala M; Juty, Nick; Kunze, John et al. (2018) Uniform resolution of compact identifiers for biomedical data. Sci Data 5:180029
Lin, Ming; Gong, Pinghua; Yang, Tao et al. (2018) Big Data Analytical Approaches to the NACC Dataset: Aiding Preclinical Trial Enrichment. Alzheimer Dis Assoc Disord 32:18-27
Ramsey, Christine M; Gnjidic, Danijela; Agogo, George O et al. (2018) Longitudinal patterns of potentially inappropriate medication use following incident dementia diagnosis. Alzheimers Dement (N Y) 4:1-10
Woerman, Amanda L; Kazmi, Sabeen A; Patel, Smita et al. (2018) Familial Parkinson's point mutation abolishes multiple system atrophy prion replication. Proc Natl Acad Sci U S A 115:409-414
Woerman, Amanda L; Kazmi, Sabeen A; Patel, Smita et al. (2018) MSA prions exhibit remarkable stability and resistance to inactivation. Acta Neuropathol 135:49-63
Kirson, Noam Y; Scott Andrews, J; Desai, Urvi et al. (2018) Patient Characteristics and Outcomes Associated with Receiving an Earlier Versus Later Diagnosis of Probable Alzheimer's Disease. J Alzheimers Dis 61:295-307

Showing the most recent 10 out of 966 publications